Centre for Community-Driven Research: Patient Events & the PEEK Study
The AGITG is working with the Centre for Community-Driven Research (http://www.cc-dr.org/au), a charity that aims to understand... Read More
AGITG Trial News
Trial news: The AGITG currently has eleven studies open to recruitment and five studies in follow up. The table below... Read More
Cancer drugs made available on PBS for gastro-intestinal cancer patients
The Department of Health has announced on Saturday 1 December that five new cancer listings have been made... Read More
How AGITG research is developed
The AGITG’s research and clinical trials are developed through a robust, scientific process. The studies we conduct are based on our strategic research priorities, which identify the areas of greatest need for patients. Our priorities include a focus on rare and underfunded cancers and areas where patients have few treatment... Read More
Targeted therapy for metastatic colorectal cancer: Slide resource for members
A slide set has been produced by Dr Matthew Burge, A/Prof Niall Tebbutt and Prof Tim Price, titled... Read More
CONTROL NETs accrues final patients
The CONTROL NETs trial in neuroendocrine tumours (NETs) has finished patient accrual and is now in follow-up. NETs are... Read More
Congratulations to the 2018 AGITG award winners
The 20th Annual AGITG Annual Scientific Meeting was held from 30 October-2 November. At the Annual Scientific Meeting... Read More
Professor John Simes recognised for a lifetime of commitment to cancer research
Professor John Simes was awarded the John Zalcberg OAM Award for Excellence in AGITG Research at the AGITG... Read More
The 20th AGITG Annual Scientific Meeting
The 20th AGITG Annual Scientific Meeting was held at the Brisbane Convention and Exhibition Centre from 31 October-2 November. Cutting-edge... Read More
New research could help unlock immunotherapy for colorectal cancer
Dr Rosemary Habib has been awarded the 2018 Merck-AGITG Kristian Anderson Award for her research that could... Read More
OXTOX fighting side effects of chemotherapy
Congratulations to Professor Janette Vardy who has has received the 2018 AGITG Innovation Fund grant for $200,000 to... Read More
What to expect at the 2018 AGITG Annual Scientific Meeting
The Australasian Gastro-Intestinal Trials Group (AGITG) is the only research organisation in the Australasian region with a focus... Read More
New numbers from AIHW released for Colorectal and Digestive-tract cancers
A first-of-its-kind report from the Australian Institute of Health and Welfare (AIHW) provides a new understanding of all... Read More
John Zalcberg & Chris Jackson call for access to treatment for New Zealand cancer patients
Professor John Zalcberg and the director of the New Zealand Cancer Society, Chris Jackson, have called for a... Read More
How the GI Cancer Institute’s research is developed
The GI Cancer Institute’s research and clinical trials are developed through a robust, scientific process. The studies we... Read More
Cutting-edge trial using stereotactic body radiotherapy in addition to modern chemotherapy to kill pancreatic cancer
Pancreatic cancer could be treated using a new form of radiotherapy that delivers highly targeted doses of radiation... Read More
AGITG Outstanding Site Award
The deadline for the AGITG Outstanding Site Award had been extended to Friday 28 September. Clinical trial sites... Read More
CAP member Brian Wall awarded Honorary Doctorate of Science
Brian Wall, a member of the GI Cancer Institute’s Consumer Advisory Panel, was awarded an Honorary Doctorate of... Read More
Blood tests could detect cancer DNA: The DYNAMIC-Pancreas trial
Pancreatic cancer is aggressive and has few long-term survivors. Long-term survival can only be achieved by surgically removing... Read More
John Zalcberg & Chris Jackson call for access to treatment for New Zealand cancer patients
Professor John Zalcberg and the director of the New Zealand Cancer Society, Dr Chris Jackson, have called for... Read More